Skip to main content
. 2022 Apr 6;12:858479. doi: 10.3389/fonc.2022.858479

Table 2.

The correlations between clinical indicators and clusters in the GSE116918 (17).

Characteristic Cluster 1 Cluster 2 P-value
Samples (n) 136 112
Age, median (IQR) 67 (64, 72) 69 (62, 73) 0.632
T stage, n (%) <0.001
 T1 39 (17.5%) 12 (5.4%)
 T2 42 (18.8%) 34 (15.2%)
 T3 41 (18.4%) 51 (22.9%)
 T4 0 (0%) 4 (1.8%)
Gleason score (GS), n (%) <0.001
 GS = 6 37 (14.9%) 5 (2%)
 GS = 7 60 (24.2%) 39 (15.7%)
 GS = 8 26 (10.5%) 26 (10.5%)
 GS = 9 13 (5.2%) 42 (16.9%)
Biochemical recurrence, n (%) 0.005
 No 115 (46.4%) 77 (31%)
 Yes 21 (8.5%) 35 (14.1%)
Metastasis, n (%) 0.041
 No 129 (52%) 97 (39.1%)
 Yes 7 (2.8%) 15 (6%)

IQR, interquartile range; GS, Gleason score.